Rong Zhou
Net Worth

Last updated:

What is Rong Zhou net worth?

The estimated net worth of Mr. Rong Zhou is at least $16,762,403 as of 13 Dec 2024. He owns shares worth $3,591,980 as insider, has earned $5,483,823 from insider trading and has received compensation worth at least $7,686,600 in Amphastar Pharmaceuticals, Inc..

What is the salary of Rong Zhou?

Mr. Rong Zhou salary is $768,660 per year as Executive Vice President of Production Center in Amphastar Pharmaceuticals, Inc..

How old is Rong Zhou?

Mr. Rong Zhou is 66 years old, born in 1959.

What stocks does Rong Zhou currently own?

As insider, Mr. Rong Zhou owns shares in one company:

Company Title Shares Price per share Total value
Amphastar Pharmaceuticals, Inc. (AMPH) Executive Vice President of Production Center 118,469 $30.32 $3,591,980

What does Amphastar Pharmaceuticals, Inc. do?

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

AMPH logo
AMPH
Amphastar Pharmaceuticals, Inc.
$30.32

Rong Zhou insider trading

Amphastar Pharmaceuticals, Inc.

Mr. Rong Zhou has made 33 insider trades between 2015-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 20,928 units of AMPH stock on 10 Jan 2022. As of 13 Dec 2024 he still owns at least 118,469 units of AMPH stock.

Transaction Date Security Shares Price per share Total value Source
Option
Employee Stock Option (right to buy) 8,000 $11.33 $90,640
Option
Common Stock 8,000 $11.33 $90,640
Sale
Common Stock 8,000 $45.23 $361,840
Option
Employee Stock Option (right to buy) 7,000 $11.33 $79,310
Sale
Common Stock 7,000 $44.43 $310,975
Option
Common Stock 7,000 $11.33 $79,310
Sale
Common Stock 6,893 $48.88 $336,930
Option
Employee Stock Option (right to buy) 6,893 $14.95 $103,050
Option
Common Stock 6,893 $14.95 $103,050
Option
Employee Stock Option (right to buy) 3,000 $14.95 $44,850
Sale
Common Srock 3,000 $48.26 $144,786
Option
Common Srock 3,000 $14.95 $44,850
Option
Common Srock 4,000 $14.95 $59,800
Option
Employee Stock Option (right to buy) 4,000 $14.95 $59,800
Sale
Common Srock 4,000 $48.35 $193,400
Sale
Common Stock 3,514 $59.58 $209,364
Option
Employee Stock Option (right to buy) 3,514 $16.19 $56,892
Option
Common Stock 3,514 $16.19 $56,892
Sale
Common Stock 4,316 $58.58 $252,831
Option
Common Stock 4,316 $14.4 $62,150
Option
Employee Stock Option (right to buy) 4,316 $14.4 $62,150
Option
Employee Stock Option (right to buy) 9,651 $11.33 $109,346
Option
Common Stock 9,651 $11.33 $109,346
Option
Common Stock 4,631 $14.95 $69,233
Option
Employee Stock Option (right to buy) 1,171 $16.19 $18,958
Option
Employee Stock Option (right to buy) 13,575 $14.4 $195,480
Option
Employee Stock Option (right to buy) 4,631 $14.95 $69,233
Option
Common Stock 13,575 $14.4 $195,480
Option
Common Stock 1,171 $16.19 $18,958
Sale
Common Stock 5,000 $51.79 $258,945
Option
Employee Stock Option (right to buy) 5,000 $14.4 $72,000
Option
Common Stock 5,000 $14.4 $72,000
Sale
Common Stock 5,000 $48.24 $241,200
Option
Employee Stock Option (right to buy) 10,000 $14.4 $144,000
Option
Common Stock 10,000 $14.4 $144,000
Sale
Common Stock 10,000 $44.21 $442,050
Option
Common Stock 7,000 $10.93 $76,510
Option
Employee Stock Option (right to buy) 7,000 $10.93 $76,510
Sale
Common Stock 13,246 $28.77 $381,087
Sale
Common Stock 7,000 $26.77 $187,390
Option
Common Stock 7,000 $10.93 $76,510
Option
Employee Stock Option (right to buy) 7,000 $10.93 $76,510
Option
Employee Stock Option (right to buy) 14,000 $10.93 $153,020
Option
Common Stock 14,000 $10.93 $153,020
Sale
Common Stock 20,928 $25.37 $530,860
Option
Common Stock 7,813 $10.48 $81,880
Option
Employee Stock Option (right to buy) 7,813 $10.48 $81,880
Sale
Common Stock 7,813 $21.67 $169,308
Option
Employee Stock Option (right to buy) 6,000 $10.48 $62,880
Option
Common Stock 6,000 $10.48 $62,880
Sale
Common Stock 9,123 $21.24 $193,736
Sale
Common Stock 6,000 N/A N/A
Option
Employee Stock Option (right to buy) 6,000 N/A N/A
Option
Common Stock 6,000 N/A N/A
Option
Common Stock 5,187 N/A N/A
Option
Employee Stock Option (right to buy) 5,187 N/A N/A
Sale
Common Stock 5,187 N/A N/A
Sale
Common Stock 4,732 N/A N/A
Sale
Common Stock 8,180 N/A N/A
Option
Employee Stock Option (right to buy) 8,180 N/A N/A
Option
Common Stock 8,180 N/A N/A
Option
Common Stock 11,120 $14.23 $158,238
Sale
Common Stock 17,419 $19.72 $343,468
Option
Employee Stock Option (right to buy) 11,120 $14.23 $158,238
Sale
Common Stock 700 $14.23 $9,961
Option
Employee Stock Option (right to buy) 700 $14.23 $9,961
Option
Common Stock 700 $14.23 $9,961
Option
Employee Stock Option (right to buy) 8,918 $11.41 $101,754
Option
Common Stock 8,918 $11.41 $101,754
Sale
Common Stock 9,806 $19.19 $188,177
Option
Employee Stock Option (right to buy) 11,082 $11.41 $126,446
Sale
Common Stock 13,163 $18.82 $247,675
Option
Common Stock 11,082 $11.41 $126,446
Sale
Common Stock 9,600 $20.26 $194,496
Option
Common Stock 9,600 $20.26 $194,496
Option
Employee Stock Option (right to buy) 9,600 $20.26 $194,496
Option
Common Stock 3,200 $20.26 $64,832
Option
Employee Stock Option (right to buy) 3,200 $20.26 $64,832
Sale
Common Stock 3,200 $20.26 $64,832
Option
Common Stock 3,200 $20.26 $64,832
Sale
Common Stock 4,289 $23 $98,647
Option
Employee Stock Option (right to buy) 6,400 $20.26 $129,664
Sale
Common Stock 1,089 $22 $23,958
Sale
Common Stock 1,089 $21 $22,869
Sale
Common Stock 1,084 $20 $21,680
Sale
Common Stock 61 $20.7 $1,262
Sale
Common Stock 1,551 $15.85 $24,583
Sale
Common Stock 772 $14.29 $11,032
Sale
Common Stock 1,000 $16.48 $16,480

Amphastar Pharmaceuticals key executives

Amphastar Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Yongfeng Zhang (78) Co-founder, Pres, Chief Executive Officer, Chief Scientific Officer & Director
  • Dr. Ziping Luo (75) Chairman, Chief Scientist & Chief Operating Officer
  • Mr. Jacob Liawatidewi M.B.A. (51) Executive Vice President of Corporation Admin. Center, Sales & Marketing and Corporation Sec.
  • Mr. Rong Zhou (66) Executive Vice President of Production Center
  • Mr. William J. Peters M.B.A. (57) Chief Financial Officer, Treasurer & Executive Vice President of Fin.